Generally, the CTLA-4 overexpressed on Tregs and PD-L1 on tumor cells could bind to the immune checkpoint proteins on T cells to inhibit T cell activation, restrain antitumor immune response, and finally construct an immune suppressive environment 217, 218. This evidence concerns the gene CTLA4 and neoplasm.